Pages Menu
TwitterRssFacebook
Categories Menu

Posted by on Jun 14, 2013 in Medical Journals |

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Head for The Masto Townhall forum to debate this paper.
This article may be copyrighted. Notice to copyright holders.
You can view the full article at the publisher here
There is a fee associated with downloading this article.
J Allergy Clin Immunol. 2007 Jun;119(6):1550-1. Epub 2007 May 3.

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Carter MC, Robyn JA, Bressler PB, Walker JC, Shapiro GG, Metcalfe DD.

PMID: 17481708 [PubMed – indexed for MEDLINE]